Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*
Structure of CEACAM 185-193 (HLA-B*07:02)
Logo for Cancer
Cancer

CEACAM 185-193 (HLA-B*07:02) LPVSPRLQL

Product number: EP11113_1

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart

Description

This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed CEACAM-derived peptide of LPVSPRLQL sequence covering 185-193 and B*07:02 molecule.

TechData

Sequence: LPVSPRLQL
Gene: CEACAM
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Carcinoembryonic antigen-related cell adhesion molecule
Species: Human
Allele: HLA-B*07:02
Application: Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication: Cancer
Purity: 95% HPLC-MS

Documents

Material data sheet Safety data sheet Storage and handling of peptides Probing of membranes with HRP
Skip product gallery

More CEA peptides

CEA 605-613 (HLA-A*02:01)
CEA 605-613 (HLA-A*02:01)
CAP1 peptide YLSGANLNL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Adenylyl Cyclase-Associated Protein 1 (CAP1) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.

From €105.00*
Details
CEA 605-613 mutant (HLA-A*02:01) 610D
CEA 605-613 mutant (HLA-A*02:01) 610D
The peptide CEA 605-613 mutant (HLA-A*02:01) 610D with the amino acid sequence YLSGADLNL is a linear peptidic epitope (epitope ID 2218585) studied as part of Cell adhesion molecule CEACAM5 (UniProt:P06731) from Homo sapiens (human).The epitope is an analog of: YLSGANLNL from Homo sapiens (human) Carcinoembryonic antigen-related cell adhesion molecule 5.CEA 605-613 mutant (HLA-A*02:01) 610D has been studied for immune reactivity in publications and has been tested in T cell assays.

From €105.00*
Details
CEA 652-660 (HLA-A*24:02)
CEA 652-660 (HLA-A*24:02)
Carcinogenic Embryonic Antigen (CEA) 652-660 is a linear peptidic epitope (epitope ID 67308) studied as part of Carcinoembryonic antigen-related cell adhesion molecule 5 from Homo sapiens (human). This epitope has been studied for immune reactivity snd was tested in T cell assays as well as MHC ligand assay

From €105.00*
Details
CEA 694-702 (HLA-A*02:01)
CEA 694-702 (HLA-A*02:01)
GVLVGVALI is a linear peptidic epitope (epitope ID137754) studied as part of Carcinoembryonic antigen-related cell adhesion molecule 5 from Homo sapiens (human)., tested in T cell assay

From €105.00*
Details
This website uses cookies to ensure the best experience possible. More information...